- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Shimadzu forms pact with Acuson
The Japanese subsidiary of Acuson has chosen Shimadzu Corp. inKyoto as its exclusive sales agent in Japan for the moderatelypriced 128 XP/4 Advanced ultrasound scanner. The accord was formedin October and announced in the Japanese press in November.
The Japanese subsidiary of Acuson has chosen Shimadzu Corp. inKyoto as its exclusive sales agent in Japan for the moderatelypriced 128 XP/4 Advanced ultrasound scanner. The accord was formedin October and announced in the Japanese press in November.
Shimadzu officials will use the 128 XP/4 Advanced to fill aneed for a mid-tier color-flow system in its domestic productline, according to Yuji Shimizu, project leader of medical systemsmarketing at Shimadzu.
"We see this as an opportunity to expand our market share,"he said.
The alliance will enable Acuson to take advantage of Shimadzu'straditionally strong relationships with physicians in Japan'scommunity and public hospitals, said Judy Barton, Acuson's marketingmanager for Asia/Pacific and Latin American regions.
The manufacturer's Japanese subsidiary Acuson Nippon will continueto provide installation, training and service support for theXP/4 installed base, Barton said. It also spearheads Acuson'ssales of the high-performance 128 XP/10 to large hospitals anduniversity-based facilities in Japan, she said. No financial termswere disclosed.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
